S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model

por Miyajima, Noriyuki, Ragab Eissa, Ibrahim, Abdelmoneim, Mohamed, Naoe, Yoshinori, Ichinose, Toru, Matsumura, Shigeru, Bustos-Villalobos, Itzel, Mukoyama, Nobuaki, Morimoto, Daishi, Shibata, Masahiro, Takeuchi, Dai, Tsunoda, Nobuyuki, Kikumori, Toyone, Tanaka, Maki, Kodera, Yasuhiro, Kasuya, Hideki
Publicado 2021